First-line therapy with moderate dose capecitabine in metastatic breast cancer is safe and active: Results of the MONICA trial - Concepedia

Concepedia

Publication | Closed Access

First-line therapy with moderate dose capecitabine in metastatic breast cancer is safe and active: Results of the MONICA trial

38

Citations

13

References

2010

Year

M. Kaufmann, Nicolaì Maass, Serban Dan Costa, Andreas Schneeweiß, Sibylle Loibl, Marc Sütterlin, Iris Schrader, B. Gerber, Wolfgang Bauer, W. Wiest,

European Journal of Cancer

Metastatic Breast CancerOncologyBreast OncologyMedicineMonica TrialCancer ManagementBreast CancerPharmacotherapyCancer TreatmentModerate Dose CapecitabinePharmacology

References

	Year	Citations

Page 1

Page 1